ReNeuron Holdings plc, the UK's only quoted stem cell company, is being taken private by its venture capital backers, the Merlin Consortium, in a recommended cash offer of 10 pence per share, valuing ReNeuron at £3.6 million (US$5.7 million). (BioWorld International) Read More
